Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Dec 9, 2025 8-K
EFFECT Nov 25, 2025
424B4 Nov 25, 2025 424B4
CORRESP Nov 24, 2025
4 Nov 12, 2025 4
SCHEDULE 13G/A Nov 7, 2025
10-Q Nov 6, 2025 10-Q
8-K Nov 6, 2025 8-K
8-K Oct 30, 2025 8-K
SCHEDULE 13G Oct 6, 2025
4 Oct 3, 2025 PRIMARY DOCUMENT
3 Oct 3, 2025 PRIMARY DOCUMENT
S-1 Oct 1, 2025 S-1
SCHEDULE 13G Sep 17, 2025
8-K Sep 16, 2025 8-K
8-K Sep 4, 2025 8-K
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G Aug 13, 2025
10-Q Aug 11, 2025 10-Q
8-K Aug 11, 2025 8-K
4 Aug 8, 2025 4
4 Aug 8, 2025 4
4 Aug 8, 2025 4
4 Aug 8, 2025 4
← Newer Page 3 of 30 · 729 filings Older →